|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
53157582
???header.onlineuser??? :
596
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"tseng ch"???jsp.browse.items-by-author.description???
Showing items 71-80 of 271 (28 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2017-07-03 |
Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes
|
Tseng, CH |
| 國家衛生研究院 |
2017-06 |
Sitagliptin may reduce breast cancer risk in women with type 2 Diabetes
|
Tseng, CH |
| 國家衛生研究院 |
2017-06 |
Metformin and lung cancer risk in patients with type 2 diabetes mellitus
|
Tseng, CH |
| 國家衛生研究院 |
2017-04-21 |
Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis
|
Tseng, CH |
| 國家衛生研究院 |
2017-03 |
Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
|
Tseng, CH |
| 國家衛生研究院 |
2017-03 |
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
|
Tseng, CH |
| 國家衛生研究院 |
2017-01 |
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
|
Tseng, CH |
| 國家衛生研究院 |
2016-12-01 |
Factors associated with cancer- and non-cancer-related deaths among Taiwanese patients with diabetes after 17 years of follow-up
|
Tseng, CH |
| 國家衛生研究院 |
2016-08-30 |
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
|
Tseng, CH |
| 國家衛生研究院 |
2016-07 |
Response to letter to the editor on comments on use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25
|
Tseng, CH |
Showing items 71-80 of 271 (28 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
|
